Rapamycin · cost & access
Rapamycin cost and how people access it
The pill is cheap; the clinical service is what you pay for. Here is the honest breakdown, and the routes that are actually legitimate.
This page exists because "how to buy rapamycin," "rapamycin cost" and "rapamycin prescription" are among the most searched questions in the whole topic — and because most pages answering them are either sales funnels or grey-market listings. Here is the sober version.
What it actually costs
Rapamycin is available as the generic drug sirolimus, which is not expensive by prescription-drug standards.[6] The dollars people spend on "longevity rapamycin" mostly go to the service wrapper: the consultation, ongoing clinician oversight and membership. Reported figures from longevity clinics put the medication itself around $64 per month, with membership fees ranging from roughly $124 per month to several hundred dollars per multi-month cycle.[1] Numbers vary by clinic and change over time, so treat these as orientation, not a quote.
The four line items nobody breaks out
When people report wildly different rapamycin costs, it is almost always because they are counting different things. There are four separate line items, and only one of them is the drug.
| Line item | What it covers | How it behaves |
|---|---|---|
| The drug | Generic sirolimus tablets, or a compounded preparation | Usually the smallest item. Weekly dosing means a month's supply is a fraction of transplant-level consumption. |
| The prescriber | Initial consultation, then periodic reviews | One-off or per-visit with an independent physician; folded into a subscription at most telehealth clinics. |
| Membership | Platform access, messaging, protocol support | The item that dominates the total at longevity clinics — reported from roughly $124/month upward.[1] |
| Monitoring | Baseline and follow-up bloodwork | Frequently omitted from advertised pricing. This is the item you should least want to skip. |
Insurance covers sirolimus for its approved indications, not for off-label longevity use — assume every line above is out of pocket.
Why the drug line is so small
Off-label longevity protocols dose once weekly, not daily. The published trial that ran longest used 5 mg or 10 mg once weekly for 48 weeks.[2] At 6 mg weekly you are consuming roughly 24–26 mg a month, where a transplant patient may take several milligrams every single day. The arithmetic is the whole reason a serious prescription drug ends up as the cheapest part of a longevity budget — and the reason a clinic quoting you "per month" is mostly quoting you for itself.
Budget for the bloodwork, not just the pills
The measures that actually moved in the published human studies are the ones worth tracking. Kraig's trial in adults aged 70–95 found statistically significant declines in haemoglobin, haematocrit and other red-cell indices at 1 mg daily over eight weeks — changes that were not clinically significant over that short window, but which you would only ever see with a blood count.[3] The PEARL trial monitored blood biomarkers throughout and reported them staying within normal ranges at weekly dosing.[2]
A defensible monitoring set, to discuss with your prescriber:
- Complete blood count — the red-cell and white-cell indices that shifted in the daily-dosing trial.
- Comprehensive metabolic panel — liver and kidney function.
- Fasting lipids — raised cholesterol and triglycerides are among the best-documented effects at higher doses.[1]
- HbA1c or fasting glucose — the mTORC2-related metabolic concern.
- Sirolimus trough level, if your clinician wants it — it tells you about drug exposure, not about ageing.
A baseline plus one or two follow-ups in the first year is a reasonable expectation. If a service is happy to ship you a prescription drug with no baseline labs at all, that tells you what kind of service it is.
The legitimate routes
| Route | What you get | Trade-off |
|---|---|---|
| Your own physician | Off-label prescription with monitoring, inside your existing medical record | Gold standard, but many GPs will decline — off-label geroscience prescribing is still unusual. |
| Longevity / geroscience clinic | A clinician who already knows the literature, structured protocols, labs bundled | Highest total cost; incentives point toward you staying on the protocol. |
| Regulated telehealth | Real consultation, prescription within its jurisdiction's rules, subscription pricing | Convenient and cheaper than a clinic; quality of oversight varies a great deal between providers. |
Questions worth asking before you pay anyone
- Which licensed clinician will be prescribing, and in which jurisdiction are they licensed?
- What baseline bloodwork do you require before the first prescription — and is it included in the price?
- What would make you tell me not to take this? (A provider with no exclusion criteria is a sales channel.)
- What is the total first-year cost including labs and follow-ups, not the headline monthly figure?
- Is the product a standard generic tablet or a compounded preparation, and from which pharmacy?
- How do I cancel, and what happens to my prescription if I do?
The routes we will not point you to
"Research chemical" vendors, overseas grey-market pharmacies and no-prescription listings are outside any quality or legal framework. Purity, dosing accuracy and even identity of the product are unverifiable, and importing prescription drugs this way is often illegal. We deliberately do not link to them.
Concrete red flags, in the order you will meet them:
- "No prescription needed." For a drug with real immune effects and a ~62-hour half-life, this is disqualifying on its own.[5]
- "For research use only" labelling on something clearly being sold for human consumption — that phrase exists to shift liability to you.
- No certificate of analysis, or one that cannot be traced to a named third-party lab.
- Crypto-only payment or no verifiable business address.
- Dosing advice from the seller. The entity profiting from your dose should not be the entity setting it.
Is it worth the money?
That is a question about evidence, not price, and we would rather answer it honestly than sell you the answer. A 2025 review asking directly what clinical evidence supports off-label rapamycin in healthy adults concluded that the safety data at low intermittent doses are reasonably reassuring while the efficacy data for healthy-adult longevity remain thin.[4] The longest longevity-specific trial to date missed its own primary endpoint.[2]
So the honest framing is: you would be paying for an intervention with a strong animal case, a replicated immune benefit in older adults, an acceptable short-term safety record at weekly dosing — and no demonstrated human lifespan effect. Some people find that a reasonable bet with a clinician's oversight. Nobody should be told it is a settled one.
For the underlying evidence and the dosing debate, start with the main rapamycin guide. For what the drug does at each dose, see rapamycin side effects and rapamycin dosage for longevity. If you are weighing rapamycin against metformin, see rapamycin vs metformin.
Frequently asked questions
How much does rapamycin cost for longevity?
The drug itself is a relatively inexpensive generic (sirolimus). What people pay for is the clinical service around it: longevity telehealth clinics have been reported charging on the order of $64/month for the medication, with membership fees ranging from roughly $124/month to several hundred dollars per multi-month cycle.
Can I buy rapamycin without a prescription?
No legitimate route exists. Rapamycin is prescription-only. Buying unregulated 'research chemical' or grey-market rapamycin online carries real safety, legality and quality risks, and we do not point to those sources.
How do people get rapamycin for longevity?
Through a licensed physician who is willing to prescribe off-label, or via a regulated longevity telehealth clinic that includes clinician oversight. Both routes involve a real consultation, not just a purchase.
Does insurance cover rapamycin for longevity?
Effectively never. Insurers cover sirolimus for its approved indications — transplant rejection prophylaxis and lymphangioleiomyomatosis — not for off-label anti-ageing use. Assume you are paying cash for the drug, the consultation and the bloodwork.
Is generic sirolimus the same as brand-name Rapamune?
Yes, in the sense that generics must demonstrate bioequivalence to the brand. Sirolimus is a narrow-therapeutic-index drug in transplant medicine, so some clinicians prefer patients stay on one manufacturer rather than switching between generics mid-course. At weekly longevity dosing this matters far less than it does in transplant care.
How long does a month of rapamycin last at longevity doses?
Longer than most people expect, because dosing is weekly rather than daily. At 6 mg once weekly you use roughly 24–26 mg per month — a fraction of a transplant patient's monthly consumption, which is why the drug line item is usually the smallest part of the bill.
What bloodwork should go with off-label rapamycin?
A sensible baseline and follow-up panel includes a complete blood count, a comprehensive metabolic panel, a fasting lipid panel and HbA1c — the measures that moved in the published trials. Some clinicians also check a sirolimus trough level. Budget for this; it is part of the real cost.
Is it legal to import rapamycin from overseas?
In most jurisdictions, importing a prescription drug for personal use without a valid prescription is not legal, and customs seizure is a routine outcome. The bigger practical problem is that you cannot verify what is in the package. We do not link to these vendors.
References
- Rapamycin for longevity: the pros, the cons, and future perspectives. Roark KM, Iffland PH. Frontiers in Aging 2025;6:1628187.Peer-reviewed review, cited 31 times.
- Influence of rapamycin on safety and healthspan metrics after one year: PEARL trial results. Moel M et al. Aging (Albany NY) 2025;17(4):908–936.48-week RCT, 5/10 mg weekly; safe, no visceral-fat change; authors employed by AgelessRx — note conflict.
- A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort. Kraig E et al. Experimental Gerontology 2018;105:53–69.n=25, aged 70–95, 1 mg daily 8 weeks; tolerable, but measurable red-cell index changes.
- What is the clinical evidence to support off-label rapamycin therapy in healthy adults?. Hands SL, Lustgarten MS, Frame AA, Rosen CJ. Aging (Albany NY) 2025.
- Sirolimus. Wikipedia.
- Definition of rapamycin. NCI Dictionary of Cancer Terms (cancer.gov).
Own a longevity or health brand?
Rapamycin.store publishes sponsored and guest posts on an aged, topically-relevant domain, and offers display advertising. Tell us what you want to promote and we'll send our current options.